Testing effectiveness (Phase 2)UnknownNCT02249026
What this trial is testing
Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study
Who this might be right for
Drug; Withdrawal Symptoms, NeonatalWithdrawalFetus and Newborn Affected by Other Maternal Medication
Gauda, Estelle B., M.D. 40